Loading…
Valiant Laboratories (VALIANTLAB)₹111.51−2.00%Pharmaceuticals
At the end of the Jun 2026 quarter, Valiant Laboratories' shareholders were: promoters 74.96%, public 25.04%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 14,336 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% |
| FIIs | 8.67% | 7.11% | 3.50% | 1.90% | 0.00% | 0.00% | 0.64% | 0.63% | 0.02% | 0.01% | 0.20% | 0.00% |
| DIIs | 1.75% | 0.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 14.62% | 17.50% | 21.54% | 23.14% | 25.04% | 25.04% | 24.40% | 23.95% | 25.02% | 25.03% | 24.84% | 25.04% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 37,422 | 15,816 | 14,909 | 14,244 | 15,184 | 15,687 | 15,031 | 14,427 | 15,070 | 14,905 | 14,652 | 14,336 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Dhanvallabh Ventures LLP | Promoter | 46.85% | 0.00 |
| Paresh Shashikant Shah | Promoter | 9.31% | 0.00 |
| Shanilal Shivji Vora | Promoter | 7.47% | 0.00 |
| Santosh Shantilal Vora | Promoter | 7.44% | 0.00 |
| Kanchan Shantilal Vora | Promoter | 3.69% | 0.00 |
| Anil Vishanji Dedhia | Public | 1.85% | +0.55 |
| Rachi Santosh Vora | Promoter | 0.02% | 0.00 |
| Varsha Paresh Shah | Promoter | 0.01% | 0.00 |
Promoters held 74.96% of Valiant Laboratories at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (down 0.20 percentage points from 0.20% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Valiant Laboratories had 14,336 shareholders at the end of the Jun 2026 quarter, against 14,427 a year earlier.
Anil Vishanji Dedhia (Public) held 1.85% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.